Meet our trust and foundation partners

The ongoing support of our Trust and Foundation partners is helping us make great strides towards a cure for childhood cancer.

The Kids’ Cancer Project is a leading national charity funding childhood cancer research. Thanks to generous community support more than $27 million has been invested into projects across Australia, including Children’s Cancer Institute. The Kids’ Cancer Project is committed to one hundred percent survival for all children with cancer while minimising the potential harmful effects of treatment.

The Apex Foundation helped found Children’s Cancer Institute in 1984 with a $1 million donation to establish its first laboratories. The Apex Foundation provides generous annual grants for our research and supports our Histone Modification Group.

The Balnaves Foundation‘s Young Researcher’s Fund has been supporting our ambitious scientists since 2008. Based on recognising the novel ideas of early career researchers, the fund is designed to provide them the opportunity to diversify their thinking.

trusts-and-foundations

Cure Brain Cancer Foundation is the largest dedicated fundraiser for brain cancer research in Australia. The Foundation funds a research program that focuses on finding more effective, less invasive new ways to treat the cancer.

The Bright Blue Police Commissioner’s Fund for Sick Kids is supporting a new research initiative into neuroblastoma, focused on uncovering why this aggressive type of cancer occurs in children.

trusts-and-foundations

The Cure Starts Now funds a program that uses robotic technology to discover innovative new treatments for diffuse pontine gliomas – a devastating, incurable brain tumour.

trusts-and-foundations

The RCD Fund supports brain cancer research, care and development in memory of the ‘awesome’ Robert ‘Connor’ Dawes. After Connor lost a 16-month battle to ependymoma, the fund was created to keep his ‘Aeternum Fortis’ (eternal strength) spirit alive.

trusts-and-foundations

The Marian and EH Flack Trust has provided funding for Children’s Cancer Institute to purchase imaging systems that enable our researchers to visualise individual cancer cells to identify critical genes and proteins.

trusts-and-foundations

The Sporting Chance Cancer Foundation provides funding for a three-year research position through the inaugural Ken Callandar Fellowship.

The Estate of the Late RT Hall generously funds Children’s Cancer Institute’s Tumour Biology & Targeting Program, which is focused on better understanding the role and function of key proteins in cancer cells.

The Fairbridge Foundation has provided funding for Children’s Cancer Institute to purchase the Tecan Digital Compound Dispenser D300 – a vital piece of research equipment.

The Roth Charitable Foundation generously provides funding, in memory of Charmaine Roth’s late mother Maisie Winkler, for the operational costs to support skilled scientists completing drug screening for new improved treatments for childhood cancer in our Drug Discovery Centre.

The ISG Foundation provides funding to progress our research towards a cure for mixed-lineage leukaemia (MLL) – a cancer that mostly affects infants and has very poor survival rates.

The Lin Huddleston Charitable Foundation supports the work of the Institute through our research support services, which are vital to ensure all researchers have the necessary equipment to carry out their work.

The Profield Foundation is a long-term partner that provides funding to establish a unique drug discovery program aimed at developing better and safer drugs for childhood cancer – in particular, neuroblastoma.

The Reuben Pelerman Benevolent Foundation funds Children’s Cancer Institute’s Minimal Residual Disease (MRD) Group, which focuses on examining acute lymphoblastic leukaemia (ALL) samples using advanced molecular diagnostic techniques.

The Ross Trust funds two of Children’s Cancer Institute’s vital programs that focus on leukaemia.

The Live for Lily Foundation fundraise in memory of Lily Hester who lost her battle with childhood cancer in 2013, to support the delivery of the national Zero Childhood Cancer personalised medicine program being led by Children’s Cancer Institute .